Machine learning–driven spleen imaging and genomics uncover a splenic connection to coronary artery disease
Abstract
Despite advances in managing traditional risk factors, coronary artery disease (CAD) remains the leading cause of mortality. Circulating hematopoietic cells influence risk for CAD separately from traditional risk factors, but the role of a key regulating organ, the spleen, is unknown. The understudied spleen is a representation of the hematopoietic system optimally suited for unbiased radiologic investigations toward mechanistic insights. Here, we leveraged deep learning to extract 107 splenic radiomic features from abdominal magnetic resonance imaging (MRI) scans of 42,059 UK Biobank participants and of 2745 Mass General Brigham Biobank (MGBB) participants. Of these, 10 features from UK Biobank were associated with CAD. Genome-wide association analysis of CAD-associated features identified 219 loci, including 9p21. Variants at 9p21, the strongest yet mechanistically elusive CAD locus, were associated with splenic features such as run-length nonuniformity, reflecting heterogeneity of continuous texture regions. Research MRI findings were consistent internally, but external clinical validation highlighted challenges in translating analyses of abdominal MRI scans to routine clinical practice because of variability in imaging protocols and greater clinical heterogeneity among patients. Our study, combining deep learning with genomics, presents a framework to uncover potential splenic involvement in CAD and emphasizes translational gaps between research and clinical radiomics.
// Source
Authors: Meghana Kamineni, Vineet K. Raghu, Zhanqing Hua, Haodong Tian, Buu Truong, Ahmed Alaa, Art Schuermans, Sam Friedman, Christopher Reeder, Romit Bhattacharya, Peter Libby, Patrick T. Ellinor, Mahnaz Maddah, Anthony Philippakis, Whitney Hornsby, Zhi Yu, Pradeep Natarajan
Institutions: Brigham and Women's Hospital, Harvard University, KU Leuven, Google (United States), University of California, Berkeley, Artificial Intelligence in Medicine (Canada), Broad Institute, Massachusetts General Hospital, Mass General Brigham, Amgen (United States), Massachusetts Department of Public Health